Self-monitoring of blood glucose in people with type 2 diabetes: Canadian diabetes association briefing document for healthcare providers

Canadian Journal of Diabetes

Volumn 35, Issue 4, 2011, Pages 317-319

  Miller, David ^a   Berard, Lori ^a   Cheng, Alice ^a   Hanna, Amir ^a   Hagerty, Donna ^a   Knip, Aileen ^a   McDougall, Peter ^a   Woo, Vince ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; CHLORPROPAMIDE; EXENDIN 4; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; INSULIN; LIRAGLUTIDE; METFORMIN; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SAXAGLIPTIN; SITAGLIPTIN; TOLBUTAMIDE;

BLOOD GLUCOSE MONITORING; CANADA; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG USE; FUNDING; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; RISK ASSESSMENT; SELF CARE;

EID: 80054090733     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(11)54003-1     Document Type: Note

References (10)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(suppl 1):S1-S201.
2. Canadian Agency for Drugs and Technologies in Health. Current utilization of blood glucose test strips in Canada. COMPUS. 2009;3(4). Available at: www.cadth.ca/media/pdf/compus_CU_Report-BGTS.pdf.Accessed September 16, 2011.
3. Canadian Agency for Drugs and Technologies in Health. Current practice analysis of health care providers and patients on self-monitoring of blood glucose. COMPUS. 2009;3(5). Available at: www.cadth.ca/ media/pdf/compus_Current_Practice_Report_Vol-3-Issue-5.pdf. Accessed September 16, 2011.
4. Canadian Agency for Drugs and Technologies in Health. Costeffectiveness of blood glucose test strips in the management of adult patients with diabetes mellitus. COMPUS. 2009;3(3). Available at: www.cadth.ca/media/pdf/BGTS_Consolidated_Economic_Report.pdf. Accessed September 16, 2011.
5. Canadian Agency for Drugs and Technologies in Health. Systematic review of use of blood glucose test strips for the management of diabetes mellitus. COMPUS. 2009;3(2). Available at: www.cadth. ca/media/pdf/BGTS_SR_Report_of_Clinical_Outcomes.pdf. Accessed September 16, 2011.
6. Canadian Agency for Drugs and Technologies in Health. Optimal therapy recommendations for the prescribing and use of blood glucose test strips. COMPUS. 2009;3(6). Available at: www.cadth.ca/media/pdf/ compus_BGTS_OT_Rec_e.pdf. Accessed September 16, 2011.
7. Canadian Agency for Drugs and Technologies in Health. Summary report: optimal prescribing and use of blood glucose test strips for selfmonitoring of blood glucose. COMPUS. 2009(December). Available at: www.cadth.ca/media/pdf/C1109_bgts_summary_report_e.pdf. Accessed September 16, 2011.
8. Canadian Diabetes Association. Response to Draft Optimal Therapy Recommendations for the Prescribing and Use of Blood Glucose Test Strips. May 21, 2009. Available at: www.diabetes.ca/documents/aboutdiabetes/ COMPUSresponse.pdf. Accessed September 16, 2011.
9. Rabi DM, Johnson JA, Edwards AL. Self-monitoring of blood glucose for individuals with type 2 diabetes not using insulin: leaving no cornerstone unturned. Can J Diabetes. 2010;34: 24-25.
10. Woo V, Cheng AYY, Hanna A, et al. Self-monitoring of blood glucose in individuals with type 2 diabetes not using insulin: commentary. Can J Diabetes. 2010;34:19-23.